<SEC-DOCUMENT>0001654954-16-003596.txt : 20161108
<SEC-HEADER>0001654954-16-003596.hdr.sgml : 20161108
<ACCEPTANCE-DATETIME>20161108063724
ACCESSION NUMBER:		0001654954-16-003596
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20161104
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20161108
DATE AS OF CHANGE:		20161108

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ChromaDex Corp.
		CENTRAL INDEX KEY:			0001386570
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				262940963
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37752
		FILM NUMBER:		161979907

	BUSINESS ADDRESS:	
		STREET 1:		10005 MUIRLANDS BLVD.
		STREET 2:		STE. G, FIRST FLOOR
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618
		BUSINESS PHONE:		949-419-0288

	MAIL ADDRESS:	
		STREET 1:		10005 MUIRLANDS BLVD.
		STREET 2:		STE. G, FIRST FLOOR
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CODY RESOURCES, INC.
		DATE OF NAME CHANGE:	20070112
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cdxc8k_nov42016.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2016 Issuer Direct Corporation -->
<title>SEC Connect</title>
</head>
<body>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 8px; border-top: 4px solid #000000; border-bottom: 1px solid #000000">
<!--style header--><br></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
UNITED STATES</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
SECURITIES AND EXCHANGE COMMISSION</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Washington, D.C. 20549</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Form 8-K</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
CURRENT REPORT</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Date of
Report (Date of earliest event reported): <font style="font-weight: bold; color: #000000">November 4,
2016</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
<font style="font-size: 21px"><font style="font-size: 24px"><font style="font-size: 35px">CHROMADEX
CORPORATION</font></font></font></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(Exact
name of registrant as specified in its charter)</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Commission
File Number: 000-53290</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr style="background-color: #ffffff">
<td style="vertical-align: bottom; width: 49%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Delaware</font></font></div>
</td>
<td style="vertical-align: bottom; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 49%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
26-2940963</font></font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: top; width: 49%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: -48px">
<font style="font-family: Times New Roman; font-size: 13px">(State
or other jurisdiction of incorporation)</font></div>
</td>
<td style="vertical-align: bottom; width: 2%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 49%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(IRS
Employer Identification No.)</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
10005 Muirlands Boulevard</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Suite G</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Irvine, California 92618</font></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(Address
of principal executive offices, including zip code)</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
949-419-0288</font></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(Registrant<font style="color: #000000">&#x2019;</font>s
telephone number, including area code)</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(Former
name or former address, if changed since last report)</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">[ ]
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">&#xA0;
<font style="color: #000000; font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 8px; border-top: 1px solid #000000; border-bottom: 4px solid #000000">
<!--style footer--><br></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px;">&#xA0;
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px;"><font style="font-weight: bold">Item
1.01&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; Entry into a
Material Definitive Agreement.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
November 4, 2016, ChromaDex Corporation (the &#x201C;Company&#x201D;)
entered into a business financing agreement (the
&#x201C;Agreement&#x201D;) with Western Alliance Bank (the
&#x201C;Lender&#x201D;), in order to establish a formula based
revolving credit line pursuant to which the Company, the
Company&#x2019;s wholly owned subsidiary, ChromaDex, Inc. (the
&#x201C;Subsidiary&#x201D;), and two wholly owned subsidiaries of the
Subsidiary, ChromaDex Analytics, Inc. and Spherix Consulting, Inc.
(together with the Company and the Subsidiary, the
&#x201C;Borrowers&#x201D;), may borrow an aggregate principal amount
of up to $5,000,000, subject to the terms and conditions of the
Agreement. The Borrowers intend to use the proceeds received under
the Agreement for working capital needs and to fund general
business requirements. Upon execution of the Agreement, the
Borrowers paid a $25,000 facility fee and a $900 due diligence fee
to Lender.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
interest rate will be calculated at a floating rate per month equal
to (a) the greater of (i) 3.50% per year or (ii) the Prime Rate
published in the Money Rates section of the Western Edition of The
Wall Street Journal, or such other rate of interest publicly
announced by Lender as its Prime Rate, plus (b) 2.50 percentage
points, plus an additional 5.00 percentage points during any period
that an event of default has occurred and is continuing. The
Borrowers&#x2019; obligations under the Agreement are secured by a
security interest in substantially all of the Borrowers&#x2019;
current and future personal property assets, including intellectual
property.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Any
borrowings, interest or other fees or obligations that the
Borrowers owe Lender pursuant to the Agreement (the
&#x201C;Obligations&#x201D;) will be become due and payable on
November 4, 2018 (the &#x201C;Maturity Date&#x201D;). If the
Agreement is terminated prior to November 4, 2017, Borrowers will
pay a termination fee of $50,000 to Lender (the &#x201C;Termination
Fee&#x201D;), provided that such Termination Fee will be waived in
the event that Borrowers refinance with Lender. The Borrowers will
also pay the Lender (a) an annual facility fee, (b) a fee upon the
issuance of each letter of credit, (c) a monthly collateral
maintenance fee equal to 0.05% of the outstanding principal balance
under the Agreement, (d) fees for any cash management services
provided by Lender and (e) a due diligence fee on the first
anniversary of the Agreement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Agreement includes quick ratio, EBDAS and minimum revenue financial
covenants.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Borrowers are also subject to a number of affirmative and
restrictive covenants, including covenants regarding delivery of
financial statements, maintenance of inventory, payment of taxes,
maintenance of insurance, dispositions of property, business
combinations or acquisitions and incurrence of additional
indebtedness, among other customary covenants. Upon the occurrence
of certain events, including but not limited to the
Borrowers&#x2019; failure to satisfy payment obligations under the
Agreement, the breach of certain of Borrowers&#x2019; other
covenants under the Agreement, or the occurrence of a material
adverse change, Lender will have the right, among other remedies,
to declare all Obligations due and payable.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Borrowers may terminate the Agreement prior to the Maturity Date at
any time upon 30 days&#x2019; notice to Lender and payment in full
of the Obligations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Pursuant
to an exclusive placement and advisory agreement by and among the
Company, Trump Securities LLC (&#x201C;Trump&#x201D;) and Credo 180,
LLC, the Company paid Trump a consulting fee of $100,000 in
connection with the execution of the Agreement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
foregoing is only a summary of the material terms of the Agreement,
and does not purport to be complete and is qualified in its
entirety by reference to the full text of the Agreement, which will
be filed as an exhibit to the Company&#x2019;s Annual Report on Form
10-K for the year ended December 31, 2016.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
November 8, 2016, the Company issued a press release announcing the
Agreement, a copy of which is attached hereto as Exhibit
99.1.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;"><font style="font-weight: bold">
Item 2.03&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; Creation of a
Direct Financial Obligation or an Obligation under an Off-Balance
Sheet Arrangement of a Registrant.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
information set forth under Item 1.01 above is hereby incorporated
by reference into Item 2.03.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;"><font style="font-weight: bold">
Item 9.01&#xA0;&#xA0;&#xA0; &#xA0;&#xA0;&#xA0; Financial Statements
and Exhibits.</font><br></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
(d)&#xA0;Exhibits.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: bottom; width: 10%; border-bottom: 2px solid rgb(0, 0, 0);">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Exhibit No.</font></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 89%; border-bottom: 2px solid rgb(0, 0, 0);">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Description</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">99.1</font></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 89%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Press
Release, dated November 8, 2016</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
SIGNATURES</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Pursuant
to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr style="background-color: #ffffff">
<td style="vertical-align: middle; width: 53%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Date:
November 8, 2016</font></div>
</td>
<td colspan="3" style="vertical-align: middle; width: 47%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">CHROMADEX
CORPORATION</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: middle; width: 53%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align: middle; width: 41%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: middle; width: 53%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 6%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">By<font style="font-style: italic; color: #000000">:</font></font></div>
</td>
<td style="vertical-align: middle; width: 34%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline"><font style="color: #000000; font-style: italic; font-family: Times New Roman; font-size: 13px">
/s/ Frank L. Jaksch, Jr.</font></font></div>
</td>
<td style="vertical-align: middle; width: 7%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: middle; width: 53%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align: middle; width: 41%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Frank
L. Jaksch, Jr.</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: middle; width: 53%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 6%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align: middle; width: 41%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Chief
Executive Officer</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
INDEX TO EXHIBITS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: bottom; width: 10%; border-bottom: 2px solid rgb(0, 0, 0);">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Exhibit No.</font></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 89%; border-bottom: 2px solid rgb(0, 0, 0);">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Description</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 10%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">99.1</font></div>
</td>
<td style="vertical-align: bottom; width: 1%;">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 89%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Press
Release, dated November 8, 2016</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>PRESS RELEASE, DATED NOVEMBER 8, 2016
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2016 Issuer Direct Corporation -->
<title>SEC Connect</title>
</head>
<body>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Exhibit 99.1</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ex99-1000.jpg"></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
ChromaDex Establishes $5 Million Credit Facility with Bridge
Bank</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold">
IRVINE, Calif., November 8, 2016</font> &#x2013; ChromaDex Corp.
(NASDAQ: <font style="text-decoration: underline; color: #0000FF">CDXC</font>), an
innovator of proprietary health, wellness and nutritional
ingredients that creates science-based solutions to dietary
supplement, food and beverage, skin care, sports nutrition, and
pharmaceutical products, announced today that it has established a
$5 million credit facility with Bridge Bank.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
credit facility will provide ChromaDex non-dilutive working capital
needed for future growth as the company continues to expand its
proprietary ingredient business.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#x201C;We
are pleased to have a business-focused bank available to the
Company as the next step in our evolution,&#x201D; said Tom Varvaro,
ChromaDex CFO. &#x201C;We look forward to working with Bridge Bank,
which has a strong record of corporate banking and credit
facilities for companies our size.&#x201D;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
About Bridge Bank</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Bridge Bank is a division of Western Alliance Bank,</font> Member
FDIC<font style="color: #000000">, the go-to bank for business in
its growing markets. Bridge Bank was founded in 2001 in Silicon
Valley to offer a better way to bank for small-market and
middle-market businesses across many industries, as well as
emerging technology companies and the private equity community.
Geared to serving both venture-backed and non-venture-backed
companies, Bridge Bank offers a broad scope of financial solutions
including growth capital, equipment and working capital credit
facilities, sustainable energy project finance, venture debt,
treasury management, asset-based lending, SBA and commercial real
estate loans, ESOP finance and a full line of international
products and services. Based in San Jose, Bridge Bank has eight
offices in major markets across the country along with Western
Alliance Bank&#x2019;s robust national platform of specialized
financial services. Western Alliance Bank is the primary subsidiary
of Phoenix-based Western Alliance Bancorporation. With $17 billion
in assets, Western Alliance Bancorporation is one of the
fastest-growing bank holding companies in the U.S.</font> and
recognized as #10 on the Forbes 2016 &#x201C;Best Banks in
America&#x201D; list. <font style="color: #000000">For more
information, visit</font> <font style="color: #000000">www.bridgebank.com</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
About ChromaDex:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">ChromaDex
leverages its complementary business units to discover, acquire,
develop and commercialize patented and proprietary ingredient
technologies that address the dietary supplement, food, beverage,
skin care and pharmaceutical markets. In addition to our ingredient
technologies unit, we also have business units focused on natural
product fine chemicals (known as "phytochemicals"), chemistry and
analytical testing services, and product regulatory and safety
consulting (known as Spherix Consulting). As a result of our
relationships with leading universities and research institutions,
we are able to discover and license early stage, IP-backed
ingredient technologies. We then utilize our in-house chemistry,
regulatory and safety consulting business units to develop
commercially viable ingredients. Our ingredient portfolio is backed
with clinical and scientific research, as well as extensive IP
protection. Our portfolio of patented ingredient technologies
includes <font style="text-decoration: underline; color: #0000FF; background-color: #FFFFFF">
NIAGEN</font><font style="font-size: 70%; vertical-align: top; text-decoration: underline; color: #0000FF; background-color: #FFFFFF">&#xAE;</font>
nicotinamide riboside; <font style="text-decoration: underline; color: #0000FF">pTeroPure</font><font style="font-size: 70%; vertical-align: top; text-decoration: underline; color: #0000FF">&#xAE;</font>
pterostilbene; <font style="text-decoration: underline; color: #0000FF">PURENERGY</font><font style="font-size: 70%; vertical-align: top; text-decoration: underline; color: #0000FF">&#xAE;</font>,
a caffeine-pTeroPure<font style="font-size: 70%; vertical-align: top">&#xAE;</font> co-crystal;
IMMULINA<font style="font-size: 70%; vertical-align: top">&#x2122;</font>, a spirulina
extract; and AnthOrigin<font style="font-size: 70%; vertical-align: top">&#x2122;</font>, anthocyanins
derived from a domestically-produced, water-extracted purple corn
husk. To learn more about ChromaDex, please visit <font style="text-decoration: underline; color: #0000FF">www.ChromaDex.com</font>.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Forward-Looking Statements:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">This
release contains forward-looking statements within the meaning of
Section&#xA0;27A of the Securities Act of 1933, as amended, and
Section&#xA0;21E of the Securities and Exchange Act of 1934, as
amended, including statements related future growth and financial
security. Statements that are not a description of historical facts
constitute forward-looking statements and may often, but not
always, be identified by the use of such words as "expects",
"anticipates", "intends", "estimates", "plans", "potential",
"possible", "probable", "believes", "seeks", "may", "will",
"should", "could" or the negative of such terms or other similar
expressions. More detailed information about ChromaDex and the risk
factors that may affect the realization of forward-looking
statements is set forth in ChromaDex's Annual Report on Form 10-K
for the fiscal year ended January 2, 2016, ChromaDex's Quarterly
Reports on Form 10-Q and other filings submitted by ChromaDex to
the SEC, copies of which may be obtained from the SEC's website at
<font style="text-decoration: underline; color: #0000FF">www.sec.gov</font>.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date hereof,
and actual results may differ materially from those suggested by
these forward-looking statements. All forward-looking statements
are qualified in their entirety by this cautionary statement and
ChromaDex undertakes no obligation to revise or update this release
to reflect events or circumstances after the date
hereof.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
ChromaDex Public Relations Contact:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Breah
Ostendorf, Director of Marketing</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">949-537-4103</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; color: #0000FF; font-size: 13px; font-family: Times New Roman">
breaho@chromadex.com</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
ChromaDex Investor Relations Contact:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Andrew
Johnson, Director of Investor Relations</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">949-419-0288</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline; color: #0000FF; font-size: 13px; font-family: Times New Roman">
andrewj@chromadex.com</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">END</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">###</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1000.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ex99-1000.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !K 8X# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MI"0!DG% "T50O=:T[3U+75W%&!ZM7-S_ !2\*P7!A-_N([J,BIA*-1V@[BE)
M1W9V=%<_IOC7P]JF!;:E#N/16.#6^KJZAE(93T(.:MIK<$T]A:***0PHHHH
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M***YSJ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=&C.\7ZY'K/PLGU2RD9!*BG*GE3W%><>"-(\2^-=+&G'49;;1X'W/)N.YSZ
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MCK_A';N\UW6(WM8EW-$I^]75?#?_ ))9-_N/_*G/6%V[NXH:5&DK*QC? _\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
